| MeSH | D000212 |
| PubChem Compound | 23709358 23665721 |
| CHEMBL | CHEMBL1200380 |
| KEGG | dr:D02764 |
| Name | Number of Reports | Reference(s) | Data Source | |
|---|---|---|---|---|
| 1 | Drug ineffective | FAERS: 4 | US FAERS | |
| 2 | Memory impairment | FAERS: 4 | US FAERS | |
| 3 | Urticaria | FAERS: 4 | US FAERS | |
| 4 | Agnosia | FAERS: 3 | US FAERS | |
| 5 | Malaise | FAERS: 3 | US FAERS | |
| 6 | Psychiatric symptom | FAERS: 3 | US FAERS | |
| 7 | Vulvitis | FAERS: 3 | US FAERS | |
| 8 | Alopecia | FAERS: 2 | US FAERS | |
| 9 | Amnesia | FAERS: 2 | US FAERS | |
| 10 | Arthralgia | FAERS: 2 | US FAERS | |
| 11 | Blood creatinine increased | FAERS: 2 | US FAERS | |
| 12 | Diplopia | FAERS: 2 | US FAERS | |
| 13 | Dyspareunia | FAERS: 2 | US FAERS | |
| 14 | Erythema | FAERS: 2 | US FAERS | |
| 15 | Lymphadenopathy | FAERS: 2 | US FAERS | |
| 16 | Myalgia | FAERS: 2 | US FAERS | |
| 17 | Nausea | FAERS: 2 | US FAERS | |
| 18 | Temperature intolerance | FAERS: 2 | US FAERS | |
| 19 | Vomiting | FAERS: 2 | US FAERS | |
| 20 | Abasia | FAERS: 1 | US FAERS | |
| 21 | Abdominal Pain | FAERS: 1 | US FAERS | |
| 22 | Accidental overdose | FAERS: 1 | US FAERS | |
| 23 | Administration site necrosis | FAERS: 1 | US FAERS | |
| 24 | Agitation | FAERS: 1 | US FAERS | |
| 25 | Alanine Aminotransferase Increased | FAERS: 1 | US FAERS | |
| 26 | Aphasia | FAERS: 1 | US FAERS | |
| 27 | Aspartate Aminotransferase Increased | FAERS: 1 | US FAERS | |
| 28 | Aspergillosis | FAERS: 1 | US FAERS | |
| 29 | Asthenia | FAERS: 1 | US FAERS | |
| 30 | Ataxia | FAERS: 1 | US FAERS | |
| 31 | Atrial Fibrillation | FAERS: 1 | US FAERS | |
| 32 | Blood creatine increased | FAERS: 1 | US FAERS | |
| 33 | Delirium | FAERS: 1 | US FAERS | |
| 34 | Disorientation | FAERS: 1 | US FAERS | |
| 35 | Dizziness | FAERS: 1 | US FAERS | |
| 36 | Drug exposure during pregnancy | FAERS: 1 | US FAERS | |
| 37 | Dysarthria | FAERS: 1 | US FAERS | |
| 38 | Eye pain | FAERS: 1 | US FAERS | |
| 39 | Febrile Neutropenia | FAERS: 1 | US FAERS | |
| 40 | General physical health deterioration | FAERS: 1 | US FAERS | |
| 41 | Hallucinations, mixed | FAERS: 1 | US FAERS | |
| 42 | Headache | FAERS: 1 | US FAERS | |
| 43 | Hypersensitivity | FAERS: 1 | US FAERS | |
| 44 | Impaired gastric emptying | FAERS: 1 | US FAERS | |
| 45 | Infection | FAERS: 1 | US FAERS | |
| 46 | Infusion site reaction | FAERS: 1 | US FAERS | |
| 47 | Injection site erythema | FAERS: 1 | US FAERS | |
| 48 | Kluver-Bucy Syndrome | FAERS: 1 | US FAERS | |
| 49 | Large intestine perforation | FAERS: 1 | US FAERS | |
| 50 | Medication crystals in urine | FAERS: 1 | US FAERS | |
| 51 | Neonatal disorder | FAERS: 1 | US FAERS | |
| 52 | Obstruction | FAERS: 1 | US FAERS | |
| 53 | Pancytopenia | FAERS: 1 | US FAERS | |
| 54 | Postoperative fever | FAERS: 1 | US FAERS | |
| 55 | Product complaint | FAERS: 1 | US FAERS | |
| 56 | Product preparation issue | FAERS: 1 | US FAERS | |
| 57 | Purpura | FAERS: 1 | US FAERS | |
| 58 | Refusal of treatment by relative | FAERS: 1 | US FAERS | |
| 59 | Scab | FAERS: 1 | US FAERS | |
| 60 | Skin necrosis | FAERS: 1 | US FAERS | |
| 61 | Skin reaction | FAERS: 1 | US FAERS | |
| 62 | Somnolence | FAERS: 1 | US FAERS | |
| 63 | Stevens-Johnson Syndrome | FAERS: 1 | US FAERS | |
| 64 | Thrombocytopenia | FAERS: 1 | US FAERS | |
| 65 | Transaminases increased | FAERS: 1 | US FAERS | |
| 66 | Vertigo | FAERS: 1 | US FAERS | |
| 67 | Extravasation | Canada Vigilance: 1 | Canada Vigilance |
Page last updated at 2020-05-25 10:01:57 (Asia/Shanghai) | You are visitor No. 120234
Copyright © 2019-2020 Laboratory of Molecular Modeling and Design, Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology. All rights reserved.